SS patients with Wnt1- and Wnt3a-positive salivary glands and those with Wnt1- and Wnt3a-negative salivary glands did not have significantly different serum and saliva levels of DKK1 and sclerostin (for each p > 0.05). This evidence concerns the gene DKK1 and synovial sarcoma.